Healthcare gainers for the week led by CLOV's meme-stock fever, CureVac falls on delay in regulatory approval for COVID vaccine



Healthcare gainers for the week led by CLOV's meme-stock fever, CureVac falls on delay in regulatory approval for COVID vaccine



READ SOURCE

See also  Nearly 35-40% of our weightage is in pharma, that story has just begun: Ravi Dharamshi

LEAVE A REPLY

Please enter your comment!
Please enter your name here